Paul D. Walker - Publications

Affiliations: 
Wayne State University, Detroit, MI, United States 

49 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Farshi P, Fyk-Kolodziej B, Krolewski DM, Walker PD, Ichinose T. Dopamine D1 receptor expression is bipolar cell type-specific in the mouse retina. The Journal of Comparative Neurology. PMID 26587737 DOI: 10.1002/Cne.23932  0.752
2013 Yao F, Walker PD, MacKenzie RG. A Tet-on system for DRD1-expressing cells. Plos One. 8: e72681. PMID 23967330 DOI: 10.1371/Journal.Pone.0072681  0.389
2011 Ostock CY, Dupre KB, Jaunarajs KL, Walters H, George J, Krolewski D, Walker PD, Bishop C. Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation. Neuropharmacology. 61: 753-60. PMID 21635907 DOI: 10.1016/J.Neuropharm.2011.05.021  0.767
2009 Bishop C, Krolewski DM, Eskow KL, Barnum CJ, Dupre KB, Deak T, Walker PD. Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats. Journal of Neuroscience Research. 87: 1645-58. PMID 19115412 DOI: 10.1002/Jnr.21978  0.782
2008 Basura GJ, Abbas AI, O'Donohue H, Lauder JM, Roth BL, Walker PD, Manis PB. Ontogeny of serotonin and serotonin2A receptors in rat auditory cortex. Hearing Research. 244: 45-50. PMID 18718516 DOI: 10.1016/J.Heares.2008.07.009  0.767
2006 Bishop C, Taylor JL, Kuhn DM, Eskow KL, Park JY, Walker PD. MDMA and fenfluramine reduce L-DOPA-induced dyskinesia via indirect 5-HT1A receptor stimulation. The European Journal of Neuroscience. 23: 2669-76. PMID 16817869 DOI: 10.1111/J.1460-9568.2006.04790.X  0.479
2006 Taylor JL, Bishop C, Ullrich T, Rice KC, Walker PD. Serotonin 2A receptor antagonist treatment reduces dopamine D1 receptor-mediated rotational behavior but not L-DOPA-induced abnormal involuntary movements in the unilateral dopamine-depleted rat. Neuropharmacology. 50: 761-8. PMID 16434065 DOI: 10.1016/J.Neuropharm.2005.12.004  0.521
2006 Campbell BM, Kreipke CW, Walker PD. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat. Neuroscience. 137: 505-17. PMID 16289829 DOI: 10.1016/J.Neuroscience.2005.09.024  0.786
2005 Sin M, Walker PD, Bouhamdan M, Quinn JP, Bannon MJ. Preferential expression of an AAV-2 construct in NOS-positive interneurons following intrastriatal injection. Brain Research. Molecular Brain Research. 141: 74-82. PMID 16153741 DOI: 10.1016/J.Molbrainres.2005.08.008  0.315
2005 Taylor JL, Bishop C, Walker PD. Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat. Pharmacology, Biochemistry, and Behavior. 81: 887-93. PMID 16023708 DOI: 10.1016/J.Pbb.2005.06.013  0.472
2005 Bishop C, Daut GS, Walker PD. Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958. Neuropharmacology. 49: 350-8. PMID 15993442 DOI: 10.1016/J.Neuropharm.2005.03.008  0.556
2005 Krolewski DM, Bishop C, Walker PD. Intrastriatal dopamine D1 receptor agonist-mediated motor behavior is reduced by local neurokinin 1 receptor antagonism. Synapse (New York, N.Y.). 57: 1-7. PMID 15858838 DOI: 10.1002/Syn.20148  0.781
2004 Bishop C, Walker PD. Intranigral antagonism of neurokinin 1 and 3 receptors reduces intrastriatal dopamine D1 receptor-stimulated locomotion in the rat. Brain Research. 1023: 126-33. PMID 15364027 DOI: 10.1016/J.Brainres.2004.07.039  0.507
2004 Thomas DM, Walker PD, Benjamins JA, Geddes TJ, Kuhn DM. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. The Journal of Pharmacology and Experimental Therapeutics. 311: 1-7. PMID 15163680 DOI: 10.1124/Jpet.104.070961  0.435
2004 Béïque JC, Campbell B, Perring P, Hamblin MW, Walker P, Mladenovic L, Andrade R. Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 4807-17. PMID 15152041 DOI: 10.1523/Jneurosci.5113-03.2004  0.627
2004 Kreipke CW, Walker PD. NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation. Synapse (New York, N.Y.). 53: 28-35. PMID 15150738 DOI: 10.1002/Syn.20035  0.719
2004 Bishop C, Tessmer JL, Ullrich T, Rice KC, Walker PD. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism. The Journal of Pharmacology and Experimental Therapeutics. 310: 687-94. PMID 15044557 DOI: 10.1124/Jpet.104.066365  0.543
2003 Bishop C, Walker PD. Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats. Neuroscience. 121: 649-57. PMID 14568025 DOI: 10.1016/S0306-4522(03)00516-5  0.562
2003 Bishop C, Kamdar DP, Walker PD. Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats. Synapse (New York, N.Y.). 50: 164-70. PMID 12923819 DOI: 10.1002/Syn.10253  0.556
2002 Campbell BM, Walker PD. Striatal tachykinin and enkephalin mRNAs are normalized by serotonin2 and NMDA manipulation following dopamine depletion. Neuroreport. 13: 5-8. PMID 11924893 DOI: 10.1097/00001756-200201210-00006  0.699
2001 Campbell BM, Walker PD. NMDA receptor antagonism modifies the synergistic regulation of striatal tachykinin gene expression induced by dopamine D(1) and serotonin(2) receptor stimulation following neonatal dopamine depletion. Brain Research. Molecular Brain Research. 93: 90-4. PMID 11532342 DOI: 10.1016/S0169-328X(01)00156-5  0.732
2001 Campbell BM, Gresch PJ, Walker PD. Neonatal dopamine depletion reveals a synergistic mechanism of mRNA regulation that is mediated by dopamine(D1) and serotonin(2) receptors and is targeted to tachykinin neurons of the dorsomedial striatum. Neuroscience. 105: 671-80. PMID 11516832 DOI: 10.1016/S0306-4522(01)00218-4  0.715
2001 Basura GJ, Walker PD. Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion. Brain Research. Molecular Brain Research. 92: 66-77. PMID 11483243 DOI: 10.1016/S0169-328X(01)00151-6  0.772
2001 Basura GJ, Zhou SY, Walker PD, Goshgarian HG. Distribution of serotonin 2A and 2C receptor mRNA expression in the cervical ventral horn and phrenic motoneurons following spinal cord hemisection. Experimental Neurology. 169: 255-63. PMID 11358440 DOI: 10.1006/Exnr.2001.7682  0.687
2001 Campbell BM, Walker PD. MK-801 prevents dopamine D1 but not serotonin 2A stimulation of striatal preprotachykinin mRNA expression. Neuroreport. 12: 953-5. PMID 11303767 DOI: 10.1097/00001756-200104170-00018  0.71
2001 Campbell BM, Walker PD. Striatal preprotachykinin mRNA levels are regulated by stimulatory agents and dopamine D1 receptor manipulation in rodent organotypic slice cultures. Brain Research. 888: 26-33. PMID 11146049 DOI: 10.1016/S0006-8993(00)02997-8  0.65
2000 Basura GJ, Walker PD. Serotonin 2A and 2C receptor biosynthesis in the rodent striatum during postnatal development: mRNA expression and functional linkage to neuropeptide gene regulation. Synapse (New York, N.Y.). 38: 216-25. PMID 11018795 DOI: 10.1002/1098-2396(200011)38:2<216::Aid-Syn12>3.0.Co;2-5  0.731
2000 Basura GJ, Walker PD. Stimulated serotonin release from hyperinnervated terminals subsequent to neonatal dopamine depletion regulates striatal tachykinin, but not enkephalin gene expression. Brain Research. Molecular Brain Research. 81: 80-91. PMID 11000480 DOI: 10.1016/S0169-328X(00)00153-4  0.742
2000 Adler JE, Walker PD. Cyclic AMP regulates substance P expression in developing and mature spinal sensory neurons. Journal of Neuroscience Research. 59: 624-31. PMID 10686590 DOI: 10.1002/(Sici)1097-4547(20000301)59:5<624::Aid-Jnr5>3.0.Co;2-L  0.325
1999 Hadley SD, Walker PD, Goshgarian HG. Effects of the serotonin synthesis inhibitor p-CPA on the expression of the crossed phrenic phenomenon 4 h following C2 spinal cord hemisection. Experimental Neurology. 160: 479-88. PMID 10619565 DOI: 10.1006/Exnr.1999.7240  0.398
1999 Hadley SD, Walker PD, Goshgarian HG. Effects of serotonin inhibition on neuronal and astrocyte plasticity in the phrenic nucleus 4 h following C2 spinal cord hemisection. Experimental Neurology. 160: 433-45. PMID 10619560 DOI: 10.1006/Exnr.1999.7238  0.424
1999 Basura GJ, Walker PD. Suppression of serotonin hyperinnervation does not alter the dysregulatory influences of dopamine depletion on striatal neuropeptide gene expression in rodent neonates. Neuroscience Letters. 274: 9-12. PMID 10530507 DOI: 10.1016/S0304-3940(99)00650-3  0.728
1999 Gresch PJ, Walker PD. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease. Neuroscience. 93: 831-41. PMID 10473249 DOI: 10.1016/S0306-4522(99)00238-9  0.405
1999 Basura GJ, Walker PD. Serotonin 2A receptor mRNA levels in the neonatal dopamine-depleted rat striatum remain upregulated following suppression of serotonin hyperinnervation. Brain Research. Developmental Brain Research. 116: 111-7. PMID 10446352 DOI: 10.1016/S0165-3806(99)00066-8  0.742
1999 Gresch PJ, Walker PD. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat. Brain Research. Molecular Brain Research. 70: 125-34. PMID 10381550 DOI: 10.1016/S0169-328X(99)00138-2  0.587
1999 Gresch PJ, Walker PD. Acute p-chloroamphetamine increases striatal preprotachykinin mRNA: role of the serotonin 2A/2C receptor. Brain Research. Molecular Brain Research. 67: 190-3. PMID 10101247 DOI: 10.1016/S0169-328X(99)00059-5  0.514
1999 Basura GJ, Walker PD. Differential sensitivity of tachykinin vs. enkephalin gene expression in the posterior striatum in response to acute p-chloroamphetamine treatment during postnatal development. Brain Research. Developmental Brain Research. 112: 155-7. PMID 9974171 DOI: 10.1016/S0165-3806(98)00170-9  0.701
1997 Shan Y, Carlock LR, Walker PD. NMDA receptor overstimulation triggers a prolonged wave of immediate early gene expression: relationship to excitotoxicity. Experimental Neurology. 144: 406-15. PMID 9168840 DOI: 10.1006/Exnr.1997.6427  0.414
1997 Walker PD, Wolf WA. Alterations in the postnatal development of striatal preprotachykinin but not preproenkephalin mRNA expression in the serotonin-depleted rat. Developmental Neuroscience. 19: 135-42. PMID 9097028 DOI: 10.1159/000111199  0.485
1996 Cummings TJ, Walker PD. Serotonin depletion exacerbates changes in striatal gene expression following quinolinic acid injection. Brain Research. 743: 240-8. PMID 9017251 DOI: 10.1016/S0006-8993(96)01053-0  0.518
1996 Walker PD, Capodilupo JG, Wolf WA, Carlock LR. Preprotachykinin and preproenkephalin mRNA expression within striatal subregions in response to altered serotonin transmission. Brain Research. 732: 25-35. PMID 8891265 DOI: 10.1016/0006-8993(96)00483-0  0.529
1996 Sall JM, Morehead M, Murphy S, Goldman H, Walker PD. Alterations in CNS gene expression in a rodent model of moderate traumatic brain injury complicated by acute alcohol intoxication. Experimental Neurology. 139: 257-68. PMID 8654528 DOI: 10.1006/Exnr.1996.0099  0.321
1995 Carlock L, Walker PD, Shan Y, Gutridge K. Transcription of the Huntington disease gene during the quinolinic acid excitotoxic cascade. Neuroreport. 6: 1121-4. PMID 7662891 DOI: 10.1097/00001756-199505300-00012  0.333
1995 Whitty CJ, Walker PD, Goebel DJ, Poosch MS, Bannon MJ. Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra. Neuroscience. 64: 419-25. PMID 7535403 DOI: 10.1016/0306-4522(94)00373-D  0.384
1993 Walker PD, Carlock LR. Timing the excitotoxic induction of heat shock protein 70 transcription. Neuroreport. 4: 699-702. PMID 8347810 DOI: 10.1097/00001756-199306000-00024  0.32
1993 Walker PD, Carlock LR. Immediate early gene activation during the initial phases of the excitotoxic cascade. Journal of Neuroscience Research. 36: 588-95. PMID 8145290 DOI: 10.1002/Jnr.490360511  0.34
1991 Walker PD, Riley LA, Hart RP, Jonakait GM. Serotonin regulation of neostriatal tachykinins following neonatal 6-hydroxydopamine lesions. Brain Research. 557: 31-6. PMID 1720996 DOI: 10.1016/0006-8993(91)90112-9  0.403
1991 Walker PD, Riley LA, Hart RP, Jonakait GM. Serotonin regulation of tachykinin biosynthesis in the rat neostriatum. Brain Research. 546: 33-9. PMID 1713119 DOI: 10.1016/0006-8993(91)91155-T  0.346
1990 Walker PD, Schotland S, Hart RP, Jonakait GM. Tryptophan hydroxylase inhibition increases preprotachykinin mRNA in developing and adult medullary raphe nuclei. Brain Research. Molecular Brain Research. 8: 113-9. PMID 1698245 DOI: 10.1016/0169-328X(90)90055-I  0.32
Show low-probability matches.